PTC Announces Further Strategic Prioritization and Associated Reduction in WorkforcePRNewsWire • 09/28/23
PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains?Zacks Investment Research • 09/20/23
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion for DMD DrugZacks Investment Research • 09/18/23
PTC Therapeutics Crashes 29% After European Regulators Reject Its Muscular Dystrophy DrugInvestors Business Daily • 09/15/23
PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient CommunityPRNewsWire • 09/07/23
PTC Therapeutics to Present Recent Data for Sepiapterin at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual SymposiumPRNewsWire • 08/28/23
PTC Therapeutics (PTCT) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/04/23
PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/03/23
PTC Therapeutics Provides Corporate Update and Reports Second Quarter Financial ResultsPRNewsWire • 08/03/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 08/03/23
CHMP Recommends Evrysdi® for Babies Under Two Months Old with Spinal Muscular AtrophyPRNewsWire • 07/21/23
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2023 Financial ResultsPRNewsWire • 07/20/23
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 07/19/23
PTC Therapeutics Co-Founder Allan Jacobson, Ph.D., Awarded 2023 Gruber Genetics PrizePRNewsWire • 07/19/23
PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial OfficerPRNewsWire • 07/17/23
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 07/13/23
PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and SepiapterinPRNewsWire • 07/11/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 07/11/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the FirmAccesswire • 07/08/23